Molecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance

por Chen, Kevin G., Sikic, Branimir I.
Publicado 2012

The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance

por Duran, George E., Sikic, Branimir I.
Publicado en PLoS One (2019)

Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet–visible high-performance liquid chromatography

por Chin, David L., Lum, Bert L., Sikic, Branimir I.
Publicado 2002

Identification of ovarian cancer driver genes by using module network integration of multi-omics data

por Gevaert, Olivier, Villalobos, Victor, Sikic, Branimir I., Plevritis, Sylvia K.
Publicado 2013

Identification of ovarian cancer driver genes by using module network integration of multi-omics data

por Gevaert, Olivier, Villalobos, Victor, Sikic, Branimir I., Plevritis, Sylvia K.
Publicado 2014

Evidence of a Role for Functional Heterogeneity in Multidrug Resistance (MDR) Transporters in Clinical Trials of P-glycoprotein Modulation in Acute Myeloid Leukemia

por Marcelletti, John F., Sikic, Branimir I., Cripe, Larry D., Paietta, Elisabeth
Publicado en Cytometry B Clin Cytom (2018)

Clinical trial designs for testing biomarker-based personalized therapies

por Lai, Tze Leung, Lavori, Philip W, Shih, Mei-Chiung I, Sikic, Branimir I
Publicado en Clin Trials (2012)

The miR‐200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR‐3 and MES‐OV cells

por Brozovic, Anamaria, Duran, George E., Wang, Yan C., Francisco, E. Brian, Sikic, Branimir I.
Publicado en Mol Oncol (2015)

Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchyma...

por Duran, George E, Wang, Yan C, Moisan, François, Francisco, E Brian, Sikic, Branimir I
Publicado en Br J Cancer (2017)

Expression and silencing of microtubule-associated protein Tau in breast cancer cells

por Spicakova, Tatiana, O’Brien, Maureen M., Duran, George E., Sweet-Cordero, Alejandro, Sikic, Branimir I.
Publicado 2010

Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis

por Willis, Scooter, Villalobos, Victor M., Gevaert, Olivier, Abramovitz, Mark, Williams, Casey, Sikic, Branimir I., Leyland-Jones, Brian
Publicado en PLoS One (2016)

A method for detecting and correcting feature misidentification on expression microarrays

por Brown Patrick O, Sikic Branimir I, Diehn Maximilian, Schaner Marci, Tu I-Ping, Botstein David, Fero Michael J
Publicado 2004-09-01

A method for detecting and correcting feature misidentification on expression microarrays

por Tu, I-Ping, Schaner, Marci, Diehn, Maximilian, Sikic, Branimir I, Brown, Patrick O, Botstein, David, Fero, Michael J
Publicado 2004

A Phase II Study of Gefitinib, 5-Fluorouracil, Leucovorin, and Oxaliplatin (IFOX) in Previously Untreated Patients with Metastatic Colorectal Cancer

por Fisher, George A., Kuo, Timothy, Ramsey, Meghan, Schwartz, Erich, Rouse, Robert V., Cho, Cheryl D., Halsey, Joanne, Sikic, Branimir I.
Publicado 2008

Chromatin-remodeling complex SWI/SNF controls multidrug resistance by transcriptionally regulating the drug efflux pump ABCB1

por Dubey, Ramin, Lebensohn, Andres, Bahrami-Nejad, Zahra, Marceau, Caleb, Champion, Magali, Gevaert, Olivier, Sikic, Branimir I., Carette, Jan E., Rohatgi, Rajat
Publicado en Cancer Res (2016)

Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures

por Juric, Dejan, Sale, Sanja, Hromas, Robert A., Yu, Ron, Wang, Yan, Duran, George E., Tibshirani, Robert, Einhorn, Lawrence H., Sikic, Branimir I.
Publicado 2005

Amplification of Whole Tumor Genomes and Gene-by-Gene Mapping of Genomic Aberrations from Limited Sources of Fresh-Frozen and Paraffin-Embedded DNA

por Bredel, Markus, Bredel, Claudia, Juric, Dejan, Kim, Young, Vogel, Hannes, Harsh, Griffith R., Recht, Lawrence D., Pollack, Jonathan R., Sikic, Branimir I.
Publicado 2005

Mechanisms of Resistance to Cabazitaxel

por Duran, George E., Wang, Yan C., Francisco, E. Brian, Rose, John C., Martinez, Francisco J., Coller, John, Brassard, Diana, Vrignaud, Patricia, Sikic, Branimir I.
Publicado en Mol Cancer Ther (2014)

Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers

por Moisan, Francois, Francisco, Edgar B., Brozovic, Anamaria, Duran, George E., Wang, Yan C., Chaturvedi, Shalini, Seetharam, Shobha, Snyder, Linda A., Doshi, Parul, Sikic, Branimir I.
Publicado en Mol Oncol (2014)

Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies

por Ansell, Stephen M., Flinn, Ian, Taylor, Matthew H., Sikic, Branimir I., Brody, Joshua, Nemunaitis, John, Feldman, Andrew, Hawthorne, Thomas R., Rawls, Tracey, Keler, Tibor, Yellin, Michael J.
Publicado en Blood Adv (2020)